Incidence and risk factors for rebleeding after emergency endoscopic hemostasis for marginal ulcer bleeding - 01/10/22
, Youxiang Chen a, Xu Shu a, b, ⁎ Highlights |
• | Marginal ulcer bleeding is a cause of nonvariceal upper gastrointestinal bleeding. |
• | Few studies have discussed the efficacy of emergency endoscopic hemostasis and risk factors for rebleeding have not been fully explored. |
• | We found that an ulcer size≥10 mm and a PLT count<100 × 10^9/L were independent risk factors for rebleeding within 30 days after endoscopic hemostasis for marginal ulcer bleeding. |
Abstract |
Background |
Marginal ulcer bleeding is a cause of upper gastrointestinal bleeding, but the efficacy of emergency endoscopic hemostasis and risk factors for rebleeding have not been fully explored. The purpose of the current study was to investigate the rebleeding rate and risk factors after emergency endoscopic hemostasis for marginal ulcer bleeding.
Methods |
We conducted a retrospective study of 105 patients who underwent emergency endoscopic hemostasis due to marginal ulcer bleeding from January 2015 to July 2021. Patients included in this study were divided into rebleeding and non-rebleeding groups.
Results |
Among the 105 patients, 15.2% (16/105) patients developed rebleeding within 30 days after endoscopic hemostasis, and 87.5% of the patients had rebleeding within 7 days. The mean age of these patients was 60.3 ± 12.3 years, and 95 of them were male. In the univariate analysis, an ulcer size ≥10 mm, a PLT count <100 × 10^9/L and an AIMS65 score ≥2 were risk factors for rebleeding. According to the multivariable analysis, an ulcer size ≥10 mm (OR: 3.715; 95% CIs: 1.060–14.250; p = 0.043) and a PLT count <100 × 10^9/L (OR: 4.480; 95% CIs: 1.099–18.908; p = 0.035) were independent risk factors for rebleeding.
Conclusion |
Emergency endoscopic hemostasis is an effective treatment for marginal ulcer bleeding. An ulcer size ≥10 mm and a PLT count <100 × 10^9/L were independent risk factors for rebleeding within 30 days after endoscopic hemostasis for marginal ulcer bleeding.
Le texte complet de cet article est disponible en PDF.Keywords : Marginal ulcer bleeding, Endoscopic hemostasis, Rebleeding, Risk factor
Plan
Vol 46 - N° 8
Article 101953- octobre 2022 Retour au numéro
Article précédent
- Long non-coding RNA plasmacytoma variant translocation 1 correlates with higher inflammation, multiple organ injury and mortality risk in acute pancreatitis, especially in severe acute pancreatitis
- Xue Liu, Ye Lin
- Top 25 cited articles on Covid-19 and IBD: A bibliometric analysis
- Ido Veisman, Noam Brakin Lederer, Offir Ukashi, Uri Kopylov, Eyal Klang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?